Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
City of Hope Medical Center
City of Hope Medical Center
University of Michigan Rogel Cancer Center
University of Southern California
University of Arizona
University of Malaga
Centre Leon Berard
Sahlgrenska University Hospital
University Hospital, Clermont-Ferrand
University College Cork
Kaiser Permanente
Indiana University
Indiana University
Jonsson Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Loma Linda University
Wake Forest University Health Sciences
Duke University
University of Nebraska
Swiss Cancer Institute